Skip to main content

New in BMC Immunology

Immunotherapy

Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA

Tumour Immunology

Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations

Cellular Immunology

The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers

Inflammation

Anti-inflammatory protein TNFα-stimulated gene-6 (TSG-6) reduces inflammatory response after brain injury in mice

Articles

BMC Series Focus Issues

September: Patient and public involvement in research

In recognition of World Patient Safety Awareness day on 17th September, the BMC Series presents a focus issue on Patient and Public Involvement (PPI) in research.  We have collated free-to-read content from across our journals - showcasing patient perspectives, research into the study of PPI, and engaging public partners as co-authors in research.

August: Breastfeeding

In celebration of World Breastfeeding week in the beginning of August,  the BMC Series presents a focus issue on Breastfeeding.  We have  collated open-access content from across our journals to highlight research into breastfeeding behaviors and care for lactating women, infant and child health, biology of breastfeeding, and more.


Announcing the launch of In Review

BMC Immunology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Aims and scope

BMC Immunology is an open access journal publishing original peer-reviewed research articles in molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system as well as clinical studies and animal models of human diseases.

The journal welcomes submissions in these broad areas of research:
Cellular immunology and immune regulation
Clinical immunology: transplants, autoimmunity, immunodeficiency and vaccines
Immunity to infection and tumours
Immunogenetics, immunogenomics and systems immunology
Allergy and hypersensitivity
Innate Immunity and inflammation
Immunometabolism


Editor

Assistant Editor

COVID-19 Announcement

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Speed
    92 days to first decision for reviewed manuscripts only
    64 days to first decision for all manuscripts
    182 days from submission to acceptance
    17 days from acceptance to publication

    Citation Impact
    3.615 - 2-year Impact Factor
    3.782 - 5-year Impact Factor
    0.997 - SNIP (Source-Normalized Impact per Paper)
    1.224 - SJR (SCImago Journal Rank)

    Usage 
    409,405 Downloads
    64 Altmetric Mentions